Skip to main content
Clinical Trials/NCT05876325
NCT05876325
Completed
Not Applicable

Leveraging Medical Legal Partnerships to Enhance Patient-Centered, Team-Based Cost Conversations With Pediatric Oncology Patients and Families

Jean Edward1 site in 1 country61 target enrollmentApril 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Financial Stress
Sponsor
Jean Edward
Enrollment
61
Locations
1
Primary Endpoint
Change in Total Financial Toxicity
Status
Completed
Last Updated
last year

Overview

Brief Summary

The overall objective of this study was to develop and evaluate FINassist (Financial and Insurance Navigation Assistance), a patient-centered, interdisciplinary team-based oncology financial and legal navigation program. The program leverages Medical Legal Partnerships to enhance cost of care conversations with pediatric oncology patients and caregivers. FINassist optimizes the team-based care model by integrating clinicians, social workers, financial navigators, and legal advocates who work in tandem to enhance cost of care conversations with patients and caregivers, identify and intervene on patient socio-legal needs, and advocate for system-level changes.

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
December 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Jean Edward
Responsible Party
Sponsor Investigator
Principal Investigator

Jean Edward

Associate Professor

University of Kentucky

Eligibility Criteria

Inclusion Criteria

  • Caregivers of patients who have any cancer or hematologic disorder diagnosis at the DanceBlue Pediatric Hematology/oncology clinic at Kentucky Children's hospital
  • Patients with childhood cancers and/or hematologic disorders at the DanceBlue Pediatric Hematology/oncology clinic at Kentucky Children's hospital
  • 18 years and older

Exclusion Criteria

  • Unable to provide consent

Outcomes

Primary Outcomes

Change in Total Financial Toxicity

Time Frame: Baseline and post intervention, approximately 12 weeks

Measured using the COmprehensive Score for financial Toxicity (COST) tool, a measure that describes the financial distress experienced by cancer patients. Scores range from 0-44 with a higher score representing better financial well-being.

Change in Participant Quality of Life (Depression)

Time Frame: Baseline and post intervention, approximately 12 weeks

Measured using the 6-item Patient-Reported Outcomes Measurement Information System PROMIS® Depression Short Form. Scores range from 6 to 30. Higher scores indicate more of the construct being measured.

Number of participants enrolled

Time Frame: 12 months

Feasibility was defined as 60% or higher enrolled participant retention and resolution of financial or legal issue (based on existing oncology financial navigation studies)

Change in PROMIS Parent Proxy Pain Interference

Time Frame: Baseline and post intervention, approximately 12 weeks

used to measure child QOL (when applicable), with summary scores for proxy measures of global health, pain interference, and fatigue Consequences of pain on relevant aspects of one's life. This includes the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities.

FINassist Adherence

Time Frame: through issue resolution up to 12 months

Adherence is defined by the percentage of participants that maintain communication with the team and provide documents necessary for issue resolution

Resolution of Socio-legal Issue

Time Frame: 12 months

Number of participants that resolved a legal or financial case as a result of FINassist

Change in PROMIS Parent Proxy Global Health

Time Frame: Baseline and post intervention, approximately 12 weeks

used to measure child QOL (when applicable), with summary scores for proxy measures of global health, pain interference, and fatigue Overall evaluation of physical, mental health, and social health.

FINassist Acceptability assessed by 5-item survey

Time Frame: Post intervention at 12 months

Acceptability is measured using a 5 item post-intervention survey of relevance, helpfulness, convenience, recommendation to others, and value. Ratings on a scale from 0 to 10 where a higher score means greater acceptability

Change in Participant Quality of Life (physical and mental)

Time Frame: Baseline and post intervention, approximately 12 weeks

Measured using the 10-item PROMIS® (Patient-Reported Outcomes Measurement Information System) Parent Proxy Global Health scale. A 7-item summary assessment of a child's self-reported health with higher scores representing better quality of life. Values range from 7-35, with higher scores representing better health.

Change in Patient-Provider Trust

Time Frame: Baseline and post intervention, approximately 12 weeks

Measured using the the Health Care Relationship (HCR) Trust Scale. The HCR-Trust scale is scored from 0 to 4 with a maximum score of 52. Higher scores represent more trust in healthcare providers

FINassist Retention

Time Frame: through study completion up to 12 months

percentage of participants that complete both pre and post-intervention surveys

Change in Participant Quality of Life (Anxiety)

Time Frame: Baseline and post intervention, approximately 12 weeks

Measured using the 4-item Patient-Reported Outcomes Measurement Information System PROMIS® Anxiety short form. Scores range from 4 to 20. Higher scores indicate more of the construct being measured.

Change in PROMIS Parent Proxy Fatigue

Time Frame: Baseline and post intervention, approximately 12 weeks

used to measure child QOL (when applicable), with summary scores for proxy measures of global health, pain interference, and fatigue Range of symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion.

Secondary Outcomes

  • Number of Participants Receiving Financial Benefit(12 months)

Study Sites (1)

Loading locations...

Similar Trials